Validation of the revised electronic version of RUCAM for diagnosis of DILI in Chinese patients
Open Access
- 11 March 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 8 (4)
Abstract
Background & Aims: The Revised Electronic Causality Assessment Method (RECAM), a computerized update of the Roussel Uclaf Causality Assessment Methodology (RUCAM), was recently proposed. In this study, we validated and compared the utility of the RECAM and RUCAM in Chinese patients with a single conventional or herbal agent-induced liver injury. Methods: In this retrospective multicenter cohort of well-established DILI and non-DILI patients from 5 centers in China, the diagnostic performance of the RUCAM and RECAM was compared by AUC analysis. The consistency was evaluated by weighted kappa. The major causes of discrepancy were explored. Results: A total of 481 DILI and 100 non-DILI patients were included. In total, 62.6% of the DILI cases were induced by conventional agents, and 37.4% were induced by herbs. The RECAM had relatively higher AUC than RUCAM for overall [0.947 (0.926–0.964) vs. 0.867 (0.836–0.893), p=0.0016], conventional agents [0.923 (0.890–0.949) vs. 0.819 (0.775–0.858), p=0.0185], and herbs [0.972 (0.941–0.989) vs.0.911 (0.866–0.944), p=0.0199]. Latency, scores associated with hepatitis B, and hepatotoxicity information of the insulting drugs were the 3 main causes for the inconsistency between RECAM and RUCAM scores. Conclusions: The RECAM had relatively better diagnostic performance than RUCAM, with a higher AUC for Chinese DILI patients. Timely updates of the LiverTox category and refinement of serum markers to exclude hepatitis B activity would further improve the applicability of RECAM in areas where the use of herbs and resolution of past HBV infections are common.Keywords
This publication has 27 references indexed in Scilit:
- Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literatureArchives of Toxicology, 2016
- RUCAM in Drug and Herb Induced Liver Injury: The UpdateInternational Journal of Molecular Sciences, 2015
- Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury NetworkHepatology, 2014
- Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical AssociationsHepatology, 2014
- Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessmentWorld Journal of Hepatology, 2014
- Drug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?Journal of Clinical and Translational Hepatology, 2013
- Causality assessment methods in drug induced liver injury: Strengths and weaknessesJournal of Hepatology, 2011
- Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: Case reports with positive rechallengeJournal of Clinical Epidemiology, 1993
- Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuriesJournal of Clinical Epidemiology, 1993
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990